Nu Skin Enterprises Inc (NUS) Class A Com Stk USD 0.001

Sell:$11.05Buy:$11.06Price decreased$0.47 (4.07%)

Prices delayed by at least 15 minutes
Sell:$11.05
Buy:$11.06
Change:Price decreased$0.47 (4.07%)
Deal now
Prices delayed by at least 15 minutes
Sell:$11.05
Buy:$11.06
Change:Price decreased$0.47 (4.07%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Nu Skin Enterprises Inc. develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. It has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. It offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.

Key people

Steven J. Lund
Executive Chairman of the Board
Ryan S. Napierski
President, Chief Executive Officer, Director
James D. Thomas
Chief Financial Officer, Executive Vice President
Chayce D. Clark
Executive Vice President, General Counsel
Steven Keith Hatchett
Executive Vice President, Chief Product Officer
Justin S. Keisel
Executive Vice President and President of Global Sales
Daniel W. Campbell
Lead Independent Director
James Winett
Director
Emma S. Battle
Independent Director
Laura Nathanson
Independent Director
Thomas R. Pisano
Independent Director
Click to see more

Key facts

  • Shares in issue
    90.25m
  • EPIC
    NUS
  • ISIN
    US67018T1051
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Major Drugs
  • Market cap
    $562.58m
  • Employees
    3,100
  • Exchange
    New York Stock Exchange
  • Index
    TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.